跳至主要内容
临床试验/CTRI/2025/04/085995
CTRI/2025/04/085995尚未招募不适用

THE EFFICACY OF SHANKHADRAV IN THE MANAGEMENT OF MOOTRASHMARI WITH SPECIAL REFERENCE TO UROLITHIASIS A RANDOMIZED CONTROLLED TRIAL

Dr Vilas Eknath Koli1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2025年5月10日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
60
试验地点
1
主要终点
Decrease in size of urinary calculi with treatment.

研究概览

简要总结

To study the efficacy of Shankhdrava in the management of Mootrashmari is the main objective of the study. It is a comparative study design to access the efficacy of shankhrava for trial group and Gokshuradi guggulu for control group.

Total 60 patients fulfilling the diagnostic criteria which are based on sign and symptoms of Urolithiasis Examination will be selected for study. Duration of total study 18 months. Duration of trial is 45days with follow up period of 45days. Patient will be selected form OPD and IPD of our own institute . On the basis of 18 to 60 year age , subject, irrespective of religion, gender and occupation.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
Participant Blinded

入排标准

年龄范围
16.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Patient presenting with sign and symptoms of Mootrashmari.
  • Patients with size of calculus from 5mm to 12 mm.
  • Patients having calculus at Kidney, Ureter, Bladder.
  • Patients between age 18 to 60 years.
  • Patients willing to participate in clinical trial with written consent.

排除标准

  • Pregnancy / Lactation Patients not willing to participate in trial.
  • Patients suffering from associated Urolithiasis with following disease will be excluded.
  • Immunocompromised patient.
  • Diabetic patients.
  • Renal failure, congenital disorders like ectopic kidney, horse shoe kidney, stricture at Uretero Vesical & Uretero Pelvic junction, neoplasm.
  • Patients having severe hydronephrosis.

结局指标

主要结局

Decrease in size of urinary calculi with treatment.

时间窗: Up to 45days

次要结局

  • Signs and symptoms of Urolithiasis will improve with treatment.(Up to 45 days)

研究者

发起方
Dr Vilas Eknath Koli
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Vilas Eknath Koli

R .T Ayurved Mahavidyalaya , Akola

研究点 (1)

Loading locations...

相似试验